review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1074-5521(96)90176-3 |
P698 | PubMed publication ID | 8939711 |
P2093 | author name string | Cheresh DA | |
Strömblad S | |||
P2860 | cites work | Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins | Q61764268 |
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization | Q71046573 | ||
Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation | Q72071485 | ||
Disruption of epithelial cell-matrix interactions induces apoptosis | Q24673611 | ||
Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures | Q24679747 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
Integrins and signal transduction pathways: the road taken | Q29547895 | ||
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels | Q29619679 | ||
Requirement of vascular integrin alpha v beta 3 for angiogenesis | Q29619681 | ||
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. | Q34733220 | ||
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin | Q35764323 | ||
Regulation of in vitro capillary tube formation by anti-integrin antibodies | Q36233262 | ||
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells | Q36676242 | ||
Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries | Q36677941 | ||
Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis | Q37357718 | ||
The extracellular matrix as a cell survival factor | Q40241699 | ||
Cell adhesion. Fibronectin and integrin knockouts come unstuck | Q40393132 | ||
Apoptosis and the cell cycle. | Q40481774 | ||
Multi-faceted regulation of cell differentiation by extracellular matrix. | Q40824976 | ||
Life, death, and the pursuit of apoptosis. | Q40942974 | ||
Integrin transmembrane signaling and cytoskeletal control | Q40952551 | ||
Dependence of cyclin E-CDK2 kinase activity on cell anchorage. | Q41237386 | ||
A link between cyclin A expression and adhesion-dependent cell cycle progression | Q41509705 | ||
Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. | Q41564910 | ||
In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrins | Q41593571 | ||
Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. | Q52244938 | ||
Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. | Q53686513 | ||
P433 | issue | 11 | |
P304 | page(s) | 881-885 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | Chemistry and Biology | Q15758410 |
P1476 | title | Integrins, angiogenesis and vascular cell survival | |
P478 | volume | 3 |
Q90321028 | A Combined Proteomics and Bioinformatics Approach Reveals Novel Signaling Pathways and Molecular Targets After Intracerebral Hemorrhage |
Q30828938 | A novel three-dimensional system to study interactions between endothelial cells and neural cells of the developing central nervous system |
Q40739616 | Ablation of microvessels in vivo upon dimerization of iCaspase-9. |
Q42414710 | Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression |
Q28592958 | Acute cellular rejection following human heart transplantation is associated with increased expression of vitronectin receptor (integrin alphavbeta3) |
Q52538950 | Agkistin, a snake venom-derived glycoprotein Ib antagonist, disrupts von Willebrand factor-endothelial cell interaction and inhibits angiogenesis. |
Q37008623 | Alpha-v integrins as therapeutic targets in oncology. |
Q37628695 | Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies |
Q37093590 | Angiogenesis in eye disease: immunity gained or immunity lost? |
Q34178886 | Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors |
Q37736273 | Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma |
Q74629369 | Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation |
Q42401332 | Avidity-controlled hydrogels for injectable co-delivery of induced pluripotent stem cell-derived endothelial cells and growth factors |
Q52958583 | Bear bile powder inhibits angiogenesis in vivo and in vitro. |
Q35817938 | Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats |
Q28208656 | Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells |
Q77988296 | Contribution of O4+ oligodendrocyte precursors and astrocytes to the glial ensheathment of vessels in the rabbit myelinated streak |
Q34124258 | Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha(v)beta(3). |
Q44356902 | Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin alphaVbeta3 antagonists |
Q31994461 | Design, synthesis and biological evaluation of nonpeptide integrin antagonists |
Q44257017 | Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo alpha(v)beta3 integrin related tumor imaging. |
Q35747992 | Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668 |
Q84597562 | Effects of Pien Tze Huang on angiogenesis in vivo and in vitro |
Q48707747 | Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling |
Q24554513 | Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo |
Q37245368 | High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model |
Q34039076 | In the hypoxic central nervous system, endothelial cell proliferation is followed by astrocyte activation, proliferation, and increased expression of the alpha 6 beta 4 integrin and dystroglycan |
Q35869077 | In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. |
Q36986801 | Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia |
Q42861335 | Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system |
Q40242440 | Inhibition of CD95-mediated apoptosis through beta 1 integrin in the HSG epithelial cell line |
Q36322769 | Integrin alphav-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen |
Q37178996 | Integrin beta 4 in neural cells |
Q37378199 | Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel |
Q44944214 | Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses |
Q33900903 | Mechanism of action in thalidomide teratogenesis |
Q36429021 | Mechanisms of angiogenesis in gliomas |
Q34467962 | Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1. |
Q36512542 | Modulation of response to tumor therapies by the extracellular matrix |
Q37282213 | Monofunctional and higher-valent platinum anticancer agents. |
Q36696450 | Nanotechnology in corneal neovascularization therapy--a review |
Q87425451 | Noninvasive and quantitative assessment of in vivo angiogenesis using RGD-based fluorescence imaging of subcutaneous sponges |
Q49918278 | PEDF Expression Affects the Oxidative and Inflammatory State of Choroidal Endothelial Cells |
Q35567928 | Positron emission tomography (PET): Expanding the horizons of oncology drug development |
Q36394255 | Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4. |
Q48337362 | Positron emission tomography of cerebral angiogenesis and TSPO expression in a mouse model of chronic hypoxia. |
Q77385007 | Progression of human aortic valve stenosis is associated with tenascin-C expression |
Q35810167 | RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins |
Q52182121 | Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium. |
Q35810000 | Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin |
Q54298816 | Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis. |
Q35546661 | Role of endothelial cell survival and death signals in angiogenesis |
Q36230877 | Snake venoms and hemostasis |
Q38288519 | Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders. |
Q34090971 | Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration |
Q35999606 | Stroma targeting nuclear imaging and radiopharmaceuticals |
Q36983844 | Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alphavbeta3 integrins. |
Q36741459 | TNF-α promotes cerebral pericyte remodeling in vitro, via a switch from α1 to α2 integrins |
Q37140413 | Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide. |
Q96109561 | The Antiangiogenic Properties of Adipose-Derived Mesenchymal Stem/Stromal Cells in Corneal Neovascularization in a Rabbit Model |
Q35848578 | The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. |
Q36908735 | The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation |
Q29620375 | The microenvironment of the tumour-host interface |
Q47143268 | Therapeutic approaches for corneal neovascularization |
Q39094877 | Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates |
Q30493883 | Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells |
Q28740612 | Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization |
Q79304449 | VEGF and vascular changes in chronic neuroinflammation |
Q46389124 | Vascular integrin signaling |
Q81041067 | Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits |
Q53207873 | Xiongshao capsule promotes angiogenesis of HUVEC via enhancing cell proliferation and up-regulating the expression of bFGF and VEGF. |
Q28283681 | p21-activated kinase 4 phosphorylation of integrin beta5 Ser-759 and Ser-762 regulates cell migration |